cloudfront

Report Detail



Pharma & HealthcareGlobal Orally Disintegrating Tablets Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414349
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Orally Disintegrating Tablets Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Orally Disintegrating Tablets Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Anti-Psychotics Drug
  • 1.2.2 Anti-Epileptics Drug
  • 1.2.3 Other
  • 1.3 Market Analysis by Applications
  • 1.3.1 CNS Diseases
  • 1.3.2 Gastrointestinal Diseases
  • 1.3.3 CVS Diseases
  • 1.3.4 Other
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Teva
    • 2.1.1 Business Overview
  • 2.1.2 Orally Disintegrating Tablets Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Teva Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Merck
  • 2.2.1 Business Overview
  • 2.2.2 Orally Disintegrating Tablets Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Merck Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Mylan
  • 2.3.1 Business Overview
  • 2.3.2 Orally Disintegrating Tablets Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Mylan Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Pfizer
  • 2.4.1 Business Overview
  • 2.4.2 Orally Disintegrating Tablets Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Pfizer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Johnson and Johnson
  • 2.5.1 Business Overview
  • 2.5.2 Orally Disintegrating Tablets Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Johnson and Johnson Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 GSK
  • 2.6.1 Business Overview
  • 2.6.2 Orally Disintegrating Tablets Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 GSK Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Otsuka
  • 2.7.1 Business Overview
  • 2.7.2 Orally Disintegrating Tablets Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Otsuka Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Eli Lilly and Company
  • 2.8.1 Business Overview
  • 2.8.2 Orally Disintegrating Tablets Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Eli Lilly and Company Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 AstraZeneca
  • 2.9.1 Business Overview
  • 2.9.2 Orally Disintegrating Tablets Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 AstraZeneca Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Bristol-Myers Squibb
  • 2.10.1 Business Overview
  • 2.10.2 Orally Disintegrating Tablets Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.11 Conquer
  • 2.11.1 Business Overview
  • 2.11.2 Orally Disintegrating Tablets Type and Applications
  • 2.11.2.1 Product A
  • 2.11.2.2 Product B
  • 2.11.3 Conquer Orally Disintegrating Tablets Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Orally Disintegrating Tablets Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Orally Disintegrating Tablets Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Orally Disintegrating Tablets Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Orally Disintegrating Tablets Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Orally Disintegrating Tablets Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Orally Disintegrating Tablets Market Analysis by Regions

    • 4.1 Global Orally Disintegrating Tablets Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Orally Disintegrating Tablets Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Orally Disintegrating Tablets Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 4.3 Europe Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 4.5 South America Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 5 North America Orally Disintegrating Tablets by Countries

    • 5.1 North America Orally Disintegrating Tablets Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Orally Disintegrating Tablets Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Orally Disintegrating Tablets Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 5.3 Canada Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 6 Europe Orally Disintegrating Tablets by Countries

    • 6.1 Europe Orally Disintegrating Tablets Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Orally Disintegrating Tablets Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Orally Disintegrating Tablets Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 6.3 UK Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 6.4 France Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 6.5 Russia Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 6.6 Italy Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Orally Disintegrating Tablets by Countries

    • 7.1 Asia-Pacific Orally Disintegrating Tablets Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Orally Disintegrating Tablets Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Orally Disintegrating Tablets Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 7.3 Japan Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 7.4 Korea Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 7.5 India Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 8 South America Orally Disintegrating Tablets by Countries

    • 8.1 South America Orally Disintegrating Tablets Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Orally Disintegrating Tablets Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Orally Disintegrating Tablets Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Orally Disintegrating Tablets by Countries

    • 9.1 Middle East and Africa Orally Disintegrating Tablets Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Orally Disintegrating Tablets Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Orally Disintegrating Tablets Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 9.3 UAE Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Orally Disintegrating Tablets Sales and Growth Rate (2013-2018)
  • 10 Global Orally Disintegrating Tablets Market Segment by Type

    • 10.1 Global Orally Disintegrating Tablets Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Orally Disintegrating Tablets Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Orally Disintegrating Tablets Revenue and Market Share by Type (2013-2018)
  • 10.2 Anti-Psychotics Drug Sales Growth and Price
  • 10.2.1 Global Anti-Psychotics Drug Sales Growth (2013-2018)
  • 10.2.2 Global Anti-Psychotics Drug Price (2013-2018)
  • 10.3 Anti-Epileptics Drug Sales Growth and Price
  • 10.3.1 Global Anti-Epileptics Drug Sales Growth (2013-2018)
  • 10.3.2 Global Anti-Epileptics Drug Price (2013-2018)
  • 10.4 Other Sales Growth and Price
  • 10.4.1 Global Other Sales Growth (2013-2018)
  • 10.4.2 Global Other Price (2013-2018)
  • 11 Global Orally Disintegrating Tablets Market Segment by Application

    • 11.1 Global Orally Disintegrating Tablets Sales Market Share by Application (2013-2018)
    • 11.2 CNS Diseases Sales Growth (2013-2018)
    • 11.3 Gastrointestinal Diseases Sales Growth (2013-2018)
    • 11.4 CVS Diseases Sales Growth (2013-2018)
    • 11.5 Other Sales Growth (2013-2018)

    12 Orally Disintegrating Tablets Market Forecast (2018-2023)

    • 12.1 Global Orally Disintegrating Tablets Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Orally Disintegrating Tablets Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Orally Disintegrating Tablets Market Forecast (2018-2023)
  • 12.2.2 Europe Orally Disintegrating Tablets Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Orally Disintegrating Tablets Market Forecast (2018-2023)
  • 12.2.4 South America Orally Disintegrating Tablets Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Orally Disintegrating Tablets Market Forecast (2018-2023)
  • 12.3 Orally Disintegrating Tablets Market Forecast by Type (2018-2023)
  • 12.3.1 Global Orally Disintegrating Tablets Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Orally Disintegrating Tablets Market Share Forecast by Type (2018-2023)
  • 12.4 Orally Disintegrating Tablets Market Forecast by Application (2018-2023)
  • 12.4.1 Global Orally Disintegrating Tablets Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Orally Disintegrating Tablets Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

      Scope of the Report:

      This report focuses on the Orally Disintegrating Tablets in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period.

      Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.

      North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.

      The worldwide market for Orally Disintegrating Tablets is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      Teva

      Merck

      Mylan

      Pfizer

      Johnson and Johnson

      GSK

      Otsuka

      Eli Lilly and Company

      AstraZeneca

      Bristol-Myers Squibb

      Conquer

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Anti-Psychotics Drug

      Anti-Epileptics Drug

      Other

      Market Segment by Applications, can be divided into

      CNS Diseases

      Gastrointestinal Diseases

      CVS Diseases

      Other

      There are 15 Chapters to deeply display the global Orally Disintegrating Tablets market.

      Chapter 1, to describe Orally Disintegrating Tablets Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Orally Disintegrating Tablets, with sales, revenue, and price of Orally Disintegrating Tablets, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Orally Disintegrating Tablets, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Orally Disintegrating Tablets market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Orally Disintegrating Tablets sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Orally Disintegrating Tablets . Industry analysis & Market Report on Orally Disintegrating Tablets is a syndicated market report, published as Global Orally Disintegrating Tablets Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Orally Disintegrating Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report